United States Antigens' Death

United States Antigens raised a round of funding on , . Investors include Dead.

U.S. Antigens is a product and services provider to the biotechnology and research markets. Products include cells, biomass and antibodies. Services offered are custom expression and monoclonal AB p…

Articles about United States Antigens' Death: